MRZ-99030 – A novel modulator of Aβ aggregation: I – Mechanism of action (MoA) underlying the potential neuroprotective treatment of Alzheimer’s disease, glaucoma and age-related macular degeneration (AMD).
May 2015, Neuropharmacology
Author: wamrhein
Effect of the Aβ aggregation modulator MRZ-99030 on retinal damage in an animal model of glaucoma.
Written by wamrhein on . Posted in References.
August 2014, Neurotoxicity Research
Cognitive-performance recovery of Alzheimer’s disease model mice by modulation of early soluble amyloidal assemblies
(D-Trp-Aib refers to the same compound as GAL-101)
Written by wamrhein on . Posted in References.
February 2009, Angewandte Chemie (International ed. in English)